In the ever-evolving field of dermatology, researchers and clinicians are constantly seeking innovative solutions to address various skin disorders. Anakinra, an exciting breakthrough in the world of dermatology, has emerged as a promising treatment option for a range of skin conditions. This article explores the diverse uses of anakinra in dermatology, shedding light on its… Read More
Naltrexone in Dermatology
In recent years, there has been a growing interest in the potential applications of naltrexone in dermatology. Naltrexone, primarily known for its role in addiction treatment, has shown promise as an effective tool in managing various skin conditions. This post explores the use of naltrexone in dermatology, shedding light on its mechanisms, benefits, and potential… Read More
Spironolactone for Hidradenitis Suppurativa
Call 973-7864-7546 for a Hidradenitis Suppurativa consultation Hidradenitis Suppurativa (HS) is a chronic inflammatory skin disease marked by recurrent nodules, abscesses and sinus tracts, typically in the body folds. It is a very challenging disease and causes great distress. The mainstay of treatment is topical antibiotics, oral antibiotics, and more recently adalimumab. Apremilast may also be… Read More
Apremilast (Otezla) For Hidradenitis Suppurativa
Hidradenits suppurativa (HS) is a chronic inflammatory skin disease marked by recurrent painful inflamed nodules, abscesses, and sinus tracts in the axilla, inguinal, and anogenital areas. Conventional treatments for HS include topical antibiotics and oral antibiotics, such as the combination of clindamycin and rifampin. More recently, the TNF-alpha inhibitor adalimumab was approved for the treatment… Read More
Hidradenitis Supparativa Information and Treatment
Call 973-763-7546 for a Hidradenitis Suppurativa Consultation What is Hidradenitis Suppurativa? Hidradenitis Suppurativa (HS) is a chronic inflammatory skin condition that affects follicles in the body folds, typically under the arms, under the breasts, the groin and genital area, buttocks, and perianal region. The clinical features of HS include recurrent painful inflammatory papules, nodules, abscesses,… Read More
HUMIRA (adalimumab) Approved for Hidradinitis Supparitiva
Recently the biologic HUMIRA (adalimumab) was approved by the FDA for the treatment of moderate to severe hidradenitis supparativa (HS), an often debilitating disease with inflammatory papules, cysts and sinuses in the groin, axilla, inframammary and buttocks areas. This is an exciting new addition to the armamentarium of treatments, which typically include topical and oral… Read More
